Creutzfeldt-Jakob disease and advanced therapy medicinal products

  • Email
  • Help
Current version

Position statement

Reference numberEMA/CHMP/CAT/BWP/353632/2010
Published28/06/2011
KeywordsCreutzfeldt-Jakob disease, gene therapy, cell therapy and tissue engineering medicinal products, donor selection criteria, tissue and blood donation
DescriptionThis document considers the risk of transmitting Creutzfeldt-Jakob disease (CJD) or variant CJD agents via the advanced therapy medicinal products.


Document history

First version

Current version

Position statement


Overview of comments


Draft position paper

Published: 28/06/2011


Published: 28/06/2011


Published: 27/07/2010


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more